Annotation In this new volume leading authorities from around the world provide an evidence-based review of the therapeutic options currently available for the management of thrombosis. Topics covered include the use of aspirin for primary and secondary prophylaxis, platelet inhibitors, glycoprotein IIb and IIa inhibitors, pentasaccharides, warfarin, and other agents. Other sections discuss the implementation of anti-thrombotic therapy in managing specific clinical conditions such as pulmonary embolism, atrial fibrillation, stroke and diabetes, or as an adjunct to other procedures such as PCI.